EP3405178
FORMULATIONS/COMPOSITIONS COMPRISING A BTK INHIBITOR
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
18.1.2017:
2.7.2025:
17700821.6
:
17.1.2037:
17.1.2026
:
FORMULATIONS/COMPOSITIONS COMPRISING A BTK INHIBITOR
18.1.2017
2.7.2025
17.1.2026
:
Janssen Pharmaceutica NV:
Turnhoutseweg 30, 2340 Beerse, BE
:
GUPTA, Manish, Kumar:
2340 Beerse, BE
:
KULKARNI, Parikshit, Rameshrao:
Pandharpur Maharashtra 413304, IN
:
KRISHNAN NAIR, Binuraj:
Dombivali East Maharashtra 421204, IN
:
201621001987:
19.1.2016:
IN
:
EP2017050964:
18.1.2017
:
A61K 31/519, A61P 3/04, A61P 17/00, A61P 17/04, A61P 19/02, A61P 19/08, A61P 19/10, A61P 29/00, A61P 35/00, A61P 35/02, A61P 37/06, A61P 43/00, A61K 9/20, A61P 37/02